Perspective Therapeutics (CATX) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Perspective Therapeutics (CATX) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -20.77% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 8.34% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 18.67% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 15.93% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -50.44% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 43.57% |
| 10 | Perspective Therapeutics | 386.08 Mn | 386.08 Mn | - | -3.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -152.10% |
| Mar 31, 2026 | -136.61% |
| Dec 31, 2025 | 77.82% |
| Mar 31, 2025 | -13.66% |
| Sep 30, 2024 | -98.20% |
| Jun 30, 2024 | -242.95% |
| Mar 31, 2024 | -206.74% |
| Dec 31, 2023 | -696.03% |
| Sep 30, 2023 | -18.04% |
| Jun 30, 2023 | 48.14% |
| Mar 31, 2023 | 38.21% |
| Dec 31, 2022 | 49.83% |
| Mar 31, 2022 | 33.92% |
| Sep 30, 2021 | 17.62% |
| Jun 30, 2021 | 26.58% |
| Mar 31, 2021 | 78.58% |
| Dec 31, 2020 | 56.72% |
| Sep 30, 2020 | 51.73% |
| Jun 30, 2020 | 25.51% |
| Mar 31, 2020 | 18.73% |